Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays a newer revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated page version. This is a versioning update rather than a substantive content change.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's version label rather than substantive content changes.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag was updated to v3.5.3, replacing v3.5.2. This represents an internal metadata update with no changes to the study details or visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.2 has been added, replacing the previous Revision: v3.5.0 on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedNew update dates (e.g., 2026-04-03, 2026-03-31) were added and older dates (e.g., 2026-03-02, 2026-02-27, 2026-02) were removed from the study record.SummaryDifference0.1%

- Check65 days agoChange DetectedNo additions or deletions are visible in the provided data; the page appears unchanged.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.